William Shakespeare serves as Executive at Theseus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, William Shakespeare has executed 2 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 6, 2023 involved exercising options for 251,084 shares valued at $80.3K.
William Shakespeare currently holds 639,408 shares of Theseus Pharmaceuticals, Inc. (THRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Shakespeare has been a net buyer of THRX stock. They have purchased $10.0K and sold $0 worth of shares.
William Shakespeare's most recent insider trade was on Nov 6, 2023, when they sold 251,084 shares at $0.32 per share.
Get notified when new Form 4 filings are submitted
| $16.00 |
| Discretionary |